Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
Aberrantly glycosylated mucin 1 (MUC1) is a recognized tumor-specific antigen on epithelial cell tumors. A wide variety of MUC1 glycopeptide anti-cancer vaccines have been formulated by many research groups. Some researchers have used MUC1 alone as an immunogen whereas other groups used different an...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2016-07-01
|
| Collection: | Vaccines |
| Sujets: | |
| Accès en ligne: | http://www.mdpi.com/2076-393X/4/3/25 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|